Show
10
20
30
40
results per page
Understand the high pathogenicity and zoonotic transmission of the COVID‑19 virus: evasion of host innate immune responses
Liang, Chen |
Lady Davis Institute for Medical Research | Operating Grant | $480,000
CIHR Quebec 2020
Read More
Mitigating the long-term impact of the COVID‑19 epidemic on cancer control and care
Franco, Eduardo L |
McGill University | Operating Grant | $232,475
CIHR Quebec 2020
Read More
La cohésion sociale est-elle possible en situation de crises multiples? L’influence des politiques publiques entourant le coronavirus (2019-nCoV) et les préjugés envers les citoyens et citoyennes d’origine chinoise
de la Sablonniere, Roxane |
Université de Montréal | Operating Grant | $351,270
CIHR Quebec 2020
Read More
COVID-19 and COPD: Important knowledge gaps in subclinical pulmonary disease in the Canadian population
Bourbeau, Jean |
McGill University | Operating Grant | $275,554
CIHR Quebec 2020
Read More
Development of small interfering RNAs (siRNAs) for the treatment of Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2)
Gatignol, Anne |
Lady Davis Institute for Medical Research | Operating Grant | $360,377
CIHR Quebec 2020
Read More
Improving the care of older adults living with dementia across Canada during the COVID‑19 pandemic: a mixed methods study to inform policy and practice
Vedel, Isabelle |
McGill University | Operating Grant | $602,522
CIHR Quebec 2020
Read More
COVID-19 household study to assess secondary attack rates and the proportion asymptomatic, including children
Tremblay, Cécile L |
Centre hospitalier de l'Université de Montréal | Operating Grant | $859,485
CIHR Quebec 2020
Read More
CODA-19: a Collaborative Data Analysis Platform to Improve Clinical Care in Patients with COVID-19
Chasse, Michael |
Centre hospitalier de l'Université de Montréal | Operating Grant | $937,950
CIHR Quebec 2020
Read More
Sex as a Biological Variable Supplement – Innovative therapeutic approaches for the 2019-novel coronavirus
Boivin, Guy |
CHU de Québec | Operating Grant | $49,780
CIHR Quebec 2020
Read More
Development of COVID-2019 main protease inhibitors as potential antivirals against the 2019 coronavirus.
Moitessier, Nicolas R |
McGill University | Operating Grant | $203,000
CIHR Quebec 2020
Read More